Showing 1,681 - 1,700 results of 163,885 for search '(( 2 a decrease ) OR ( 5 ((we decrease) OR (((teer decrease) OR (mean decrease)))) ))', query time: 2.04s Refine Results
  1. 1681

    A long-term "memory" of HIF induction in response to chronic mild decreased oxygen after oxygen normalization-4 by Chandrashekhar D Kamat (60176)

    Published 2011
    “…Acute hypoxia (2.5% 0; 4 hours – "AH") was used as a positive control for the induction of each of the target protein. …”
  2. 1682
  3. 1683
  4. 1684

    Knockdown of <i>CPT1A</i> inactivates most of fatty acid oxidation (FAO) and decreases cellular proliferation. by Cong-Hui Yao (2013793)

    Published 2018
    “…(C) The decrease in cellular proliferation cannot be rescued by various concentrations of acetate (<i>n</i> = 5). …”
  5. 1685
  6. 1686
  7. 1687
  8. 1688

    <b>Dihydroxyacetone decreases the dATP pool, inducing replication stress and genomic instability in BEAS-2B cells</b> by Saddam Hussain (22282372)

    Published 2025
    “…Using a DNA fiber assay we observed decreased replication fork progression, which coincided with increased micronuclei formation. …”
  9. 1689

    S1 Data - by Jordan A. Gunning (18143970)

    Published 2024
    “…Specifically, total immune cells (CD45+) decrease at days 2 and 5 following IR, macrophages (F4/80+CD11b+) decrease at day 2 and 5 and increase at day 30, while neutrophils (Ly6G+CD11b+) significantly increase at day 30 following IR. …”
  10. 1690
  11. 1691

    Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…Ruxolitinib, a JAK/STAT inhibitor, has been shown to improve cutaneous manifestations of SLE. We hypothesize that the addition of ruxolitinib to UCB-Tregs may improve SLE outcomes.…”
  12. 1692
  13. 1693
  14. 1694
  15. 1695
  16. 1696
  17. 1697

    S2 Data - by Dwight D. Harris (14484648)

    Published 2024
    “…Immunoblot showed a reduction in Jak2, the pSTAT3 to STAT 3 Ratio, pSMAD 2/3, and SMAD 2/3, and an increase in STAT 3 in the SIT group relative to CON (all p<0.05). …”
  18. 1698
  19. 1699
  20. 1700